NCT06264544View on ClinicalTrials.gov

Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

October 15, 2025

Study Completion Date

December 30, 2025

Conditions
Thyrotoxicosis
Interventions
DIETARY_SUPPLEMENT

zinc, selenium, and L-tyrosine in SEPP1

zinc, selenium, and L-tyrosine in SEPP1 polymorphism

OTHER

Placebo

placebo comparator in SEPP1 polymorphism group

Trial Locations (1)

630090

Center of New Medical Technologies, Novosibirsk

Sponsors
All Listed Sponsors
collaborator

Center of New Medical Technologies

OTHER

lead

S.LAB (SOLOWAYS)

OTHER

NCT06264544 - Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism | Biotech Hunter | Biotech Hunter